The U.S. Food and Drug Administration (FDA) has announced the approval of lurbinectedin (Zepzelca; Jazz Pharmaceuticals) in...
Day: October 7, 2025
At The University of Texas MD Anderson Cancer Center, a dedicated opioid stewardship program is setting a...
The battle against the opioid epidemic requires more than just new medications; it demands a transformation in...
In a setting often overlooked by standard regulations, the University of Texas MD Anderson Cancer Center has...
A systematic review and meta-analysis recently published in Human Vaccines & Immunotherapeutics has strongly affirmed the effectiveness...
The Food and Drug Administration (FDA) has approved a second generic version of the abortion medication mifepristone...
